📣 VC round data is live. Check it out!

Orthofix Medical Valuation Multiples

Discover Orthofix Medical's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Coltene, Myriad Genetics, Medios, Perspective Therapeutics and more.

Orthofix Medical Overview

About Orthofix Medical

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.


Founded

1987

HQ

United States

Employees

1.6K

Financials (LTM)

Revenue: $831M
EBITDA: $87M

EV

$535M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Orthofix Medical Financials

Orthofix Medical reported last 12-month revenue of $831M and EBITDA of $87M.

In the same LTM period, Orthofix Medical generated $587M in gross profit, $87M in EBITDA, and $11M in net income.

Revenue (LTM)


Orthofix Medical P&L

In the most recent fiscal year, Orthofix Medical reported revenue of $822M and EBITDA of $83M.

Orthofix Medical is profitable as of last fiscal year, with gross margin of 69%, EBITDA margin of 10%, and net margin of 3%.

See analyst estimates for Orthofix Medical
LTMLast FY202320242025202620272028
Revenue$831M$822M$747M$799M$822M
Gross Profit$587M$566M$486M$546M$566M
Gross Margin71%69%65%68%69%
EBITDA$87M$83M($79M)($18M)$10M
EBITDA Margin10%10%(11%)(2%)1%
EBIT Margin(7%)(10%)(19%)(10%)(10%)
Net Profit$11M$21M($151M)($126M)($92M)
Net Margin1%3%(20%)(16%)(11%)
Net Debt-$75M---

Financial data powered by Morningstar, Inc.

Orthofix Medical Stock Performance

Orthofix Medical has current market cap of $393M, and enterprise value of $535M.

Market Cap Evolution


Orthofix Medical's stock price is $9.72.

Orthofix Medical share price increased by 4.9% in the last 30 days, and decreased by 12.8% in the last year.

Orthofix Medical has an EPS (earnings per share) of $0.52.

See more trading valuation data for Orthofix Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$535M$393M4.9%4.9%-15.3%-12.8%$0.52

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Orthofix Medical Valuation Multiples

Orthofix Medical trades at 0.6x EV/Revenue multiple, and 6.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Orthofix Medical

EV / Revenue (LTM)


Orthofix Medical Financial Valuation Multiples

As of June 3, 2026, Orthofix Medical has market cap of $393M and EV of $535M.

Orthofix Medical has a P/E ratio of 35.9x.

LTMLast FY202320242025202620272028
EV/Revenue0.6x0.7x0.7x0.7x0.7x
EV/EBITDA6.2x6.4x(6.7x)(29.3x)53.8x
EV/EBIT(8.7x)(6.6x)(3.8x)(6.9x)(6.5x)
EV/Gross Profit0.9x0.9x1.1x1.0x0.9x
P/E35.9x18.8x(2.6x)(3.1x)(4.3x)
EV/FCF(89.6x)n/m(5.0x)(58.9x)n/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Orthofix Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Orthofix Medical Margins & Growth Rates

Orthofix Medical grew revenue by 3% and EBITDA by 11% in the last fiscal year.

In the most recent fiscal year, Orthofix Medical reported gross margin of 69%, EBITDA margin of 10%, and net margin of 3%.

See estimated margins and future growth rates for Orthofix Medical

Orthofix Medical Margins

Last FY202420252026202720282029
Gross Margin69%68%69%72%
EBITDA Margin10%(2%)1%11%
EBIT Margin(10%)(10%)(10%)(4%)
Net Margin3%(16%)(11%)(0%)
FCF Margin(0%)(1%)(0%)(1%)

Orthofix Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth3%7%3%3%
Gross Profit Growth7%12%4%7%
EBITDA Growth11%(77%)(154%)826%
EBIT Growth(57%)(45%)6%(58%)
Net Profit Growth(113%)(17%)(27%)(97%)
FCF Growth895%(92%)(86%)873%

Data powered by FactSet, Inc. and Morningstar, Inc.

Orthofix Medical Operational KPIs

Orthofix Medical's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.4M for the same period.

Orthofix Medical's Rule of 40 is 13% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Orthofix Medical's Rule of X is 17% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Orthofix Medical
LTMLast FY202320242025202620272028
Rule of 4014%13%---
Bessemer Rule of X20%17%---
Revenue per Employee-$0.5M---
Opex per Employee-$0.4M---
S&M Expenses to Revenue--52%--
G&A Expenses to Revenue--19%--
R&D Expenses to Revenue8%8%11%9%8%
Opex to Revenue-79%84%78%79%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Orthofix Medical Competitors

Orthofix Medical competitors include Coltene, Myriad Genetics, Medios, Perspective Therapeutics, TaiDoc Technology, Universal Vision, IVF hartmann, ClearPoint Neuro, Vicenne and Delcath Systems.

Most Orthofix Medical public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Coltene1.3x1.4x11.4x11.1x
Myriad Genetics0.6x0.6x12.7x12.8x
Medios0.3x0.2x7.5x5.4x
Perspective Therapeutics162.7x213.0x(1.4x)(1.2x)
TaiDoc Technology1.8x-4.1x-
Universal Vision2.5x2.5x5.6x5.8x
IVF hartmann1.1x-7.0x-
ClearPoint Neuro10.8x9.1x(26.2x)(23.0x)

This data is available for Pro users. Sign up to see all Orthofix Medical competitors and their valuation data.

Start Free Trial

Acquisitions by Orthofix Medical

Orthofix Medical has acquired 2 companies to date.

Last acquisition by Orthofix Medical was on October 11th 2022. Orthofix Medical acquired SeaSpine for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Orthofix Medical

SeaSpine
Spinal Kinetics
Description
SeaSpine is a Carlsbad, California-headquartered medical technology company developing orthobiologics and spinal hardware for fusion procedures addressing lumbar, thoracic, and cervical spine disorders. Its portfolio includes bone graft substitutes, interbody devices, and plating systems used by neurosurgeons and orthopedic surgeons worldwide. Acquired by Orthofix Medical in 2023, SeaSpine operates globally with manufacturing in the U.S. and Ireland.
Spinal Kinetics is a developer of artificial disc replacement systems for degenerative spine conditions. The M6-Cervical and M6-Lumbar discs replicate natural disc anatomy with a polyethylene nucleus inside a titanium carbide annulus, available in multiple sizes for anterior cervical and lumbar implantation. Headquartered in Sunnyvale, California, the company secured CE Mark approval for both platforms in Europe starting 2007 and conducted US pivotal trials under FDA investigational device exemption. Spinal Kinetics partners with surgeons for motion-preserving alternatives to fusion in patients aged 21 to 65.
HQ CountryUnited StatesUnited States
HQ City
San Diego, CA
San Francisco, CA
Deal Date11 Oct 202215 Mar 2018
Valuationundisclosed$105M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Orthofix Medical acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Orthofix Medical

Orthofix Medical has invested in 1 company to date.

Latest investment by Orthofix Medical was on September 22nd 2020. Orthofix Medical invested in Neo Medical in their $10M Strategic investment round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Orthofix Medical

Neo Medical
Description
Neo Medical is a Geneva-headquartered medical device company focused on spinal implants and instrumentation. It offers the Kodiak system for thoracolumbar fusion and the Discure prosthesis for motion preservation, distributed in Europe and the United States with FDA clearance.
HQ CountrySwitzerland
HQ City
Vaud
Deal Date22 Sep 2020
RoundStrategic investment
Raised$10M
InvestorsOrthofix Medical
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Orthofix Medical investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Orthofix Medical

When was Orthofix Medical founded?Orthofix Medical was founded in 1987.
Where is Orthofix Medical headquartered?Orthofix Medical is headquartered in United States.
How many employees does Orthofix Medical have?As of today, Orthofix Medical has over 1K employees.
Who is the CEO of Orthofix Medical?Orthofix Medical's CEO is Massimo Calafiore.
Is Orthofix Medical publicly listed?Yes, Orthofix Medical is a public company listed on Nasdaq.
What is the stock symbol of Orthofix Medical?Orthofix Medical trades under OFIX ticker.
When did Orthofix Medical go public?Orthofix Medical went public in 1992.
Who are competitors of Orthofix Medical?Orthofix Medical main competitors include Coltene, Myriad Genetics, Medios, Perspective Therapeutics, TaiDoc Technology, Universal Vision, IVF hartmann, ClearPoint Neuro, Vicenne, Delcath Systems.
What is the current market cap of Orthofix Medical?Orthofix Medical's current market cap is $393M.
What is the current revenue of Orthofix Medical?Orthofix Medical's last 12 months revenue is $831M.
What is the current revenue growth of Orthofix Medical?Orthofix Medical revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Orthofix Medical?Current revenue multiple of Orthofix Medical is 0.6x.
What is the current EBITDA of Orthofix Medical?Orthofix Medical's last 12 months EBITDA is $87M.
What is Orthofix Medical's EBITDA margin?Orthofix Medical's last 12 months EBITDA margin is 10%.
What is the current EV/EBITDA multiple of Orthofix Medical?Current EBITDA multiple of Orthofix Medical is 6.2x.
What is the current FCF of Orthofix Medical?Orthofix Medical's last 12 months FCF is ($6M).
What is Orthofix Medical's FCF margin?Orthofix Medical's last 12 months FCF margin is (1%).
What is the current EV/FCF multiple of Orthofix Medical?Current FCF multiple of Orthofix Medical is (89.6x).
How many companies Orthofix Medical has acquired to date?As of June 2026, Orthofix Medical has acquired 2 companies.
What was the largest acquisition by Orthofix Medical?$105M acquisition of Spinal Kinetics on 15th March 2018 was the largest M&A Orthofix Medical has done to date.
What companies Orthofix Medical acquired?Orthofix Medical acquired Spinal Kinetics and SeaSpine.
In how many companies Orthofix Medical has invested to date?As of June 2026, Orthofix Medical has invested in 1 company.
What was the last Orthofix Medical investment?On 22nd September 2020 Orthofix Medical invested in Neo Medical, participating in a $10M Strategic investment round.
In what companies Orthofix Medical invested in?Orthofix Medical invested in Neo Medical.

See public comps similar to Orthofix Medical

Lists including Orthofix Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial